Insider Trades42 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | Sell | DBD | Thomas S Timko | EVP, CFO | 1,344 | $81.35 | $3.0B | -3.80% | +58.85% | $109.3K | +0.00% | — | Buy Now |
| May 26, 2026 | Buy | DBD | Octavio Marquez | President and CEO | 1,250 | $79.47 | $3.0B | -3.80% | +58.85% | $99.3K | +0.29% | — | Buy Now |
| May 22, 2026 | Buy | DBD | Thomas S Timko | EVP, CFO | 672 | $74.36 | $3.0B | -3.80% | +58.85% | $50.0K | +0.90% | — | Buy Now |
| May 22, 2026 | Buy | DBD | Jonathan Myers | EVP, Chief Revenue Officer | 1,360 | $73.41 | $3.0B | -3.80% | +58.85% | $99.8K | +3.07% | — | Buy Now |
| Mar 7, 2026 | Sell | DBD | Octavio Marquez | President and CEO | 10,549 | $77.58 | $3.0B | -3.80% | +58.85% | $818.4K | -4.65% | — | Buy Now |
| Mar 1, 2026 | Sell | DBD | Jeffrey M Sesplankis | SVP, Chief Accounting Officer | 672 | $80.00 | $3.0B | -3.80% | +58.85% | $53.8K | -11.58% | — | Buy Now |
| Mar 1, 2026 | Sell | DBD | Elizabeth Christine Radigan | EVP, Chief Administrative Ofcr | 1,944 | $80.00 | $3.0B | -3.80% | +58.85% | $155.5K | -8.14% | — | Buy Now |
| Mar 1, 2026 | Sell | DBD | Frank Tobias Baur | EVP, Chief Operating Officer | 2,876 | $80.00 | $3.0B | -3.80% | +58.85% | $230.1K | -7.60% | — | Buy Now |
| Mar 1, 2026 | Sell | DBD | Jonathan Myers | EVP, Chief Revenue Officer | 2,905 | $80.00 | $3.0B | -3.80% | +58.85% | $232.4K | -7.70% | — | Buy Now |
| Mar 1, 2026 | Sell | DBD | Thomas S Timko | EVP, CFO | 7,553 | $80.00 | $3.0B | -3.80% | +58.85% | $604.2K | -11.26% | — | Buy Now |
| Mar 1, 2026 | Sell | DBD | Octavio Marquez | President and CEO | 9,119 | $80.00 | $3.0B | -3.80% | +58.85% | $729.5K | -4.76% | — | Buy Now |
| Jan 19, 2026 | Sell | DBD | Frank Tobias Baur | EVP, Chief Operating Officer | 716 | $69.91 | $3.0B | -3.80% | +58.85% | $50.1K | -1.86% | — | Buy Now |
| Jan 19, 2026 | Sell | DBD | Elizabeth Christine Radigan | EVP, Chief Administrative Ofcr | 757 | $69.91 | $3.0B | -3.80% | +58.85% | $52.9K | -3.07% | — | Buy Now |
| Jan 19, 2026 | Sell | DBD | Jonathan Myers | EVP, Chief Revenue Officer | 1,047 | $69.91 | $3.0B | -3.80% | +58.85% | $73.2K | -2.70% | — | Buy Now |
| Jan 19, 2026 | Sell | DBD | Thomas S Timko | EVP, CFO | 1,439 | $69.91 | $3.0B | -3.80% | +58.85% | $100.6K | -2.10% | — | Buy Now |
| Jan 19, 2026 | Sell | DBD | Octavio Marquez | President and CEO | 3,136 | $69.91 | $3.0B | -3.80% | +58.85% | $219.2K | -1.61% | — | Buy Now |
| May 9, 2025 | Buy | DBD | Frank Tobias Baur | EVP of Operational Excellence | 700 | $46.12 | $3.0B | -3.80% | +58.85% | $32.3K | +1.85% | — | Buy Now |
| Mar 7, 2025 | Sell | DBD | Octavio Marquez | President and CEO | 9,036 | $43.73 | $3.0B | -3.80% | +58.85% | $395.1K | -4.43% | — | Buy Now |
| Mar 1, 2025 | Sell | DBD | Kathleen Ann Creech | EVP, CHRO | 849 | $44.23 | $3.0B | -3.80% | +58.85% | $37.6K | -5.31% | — | Buy Now |
| Mar 1, 2025 | Sell | DBD | Elizabeth Christine Radigan | EVP - Chief Legal Officer | 1,043 | $44.23 | $3.0B | -3.80% | +58.85% | $46.1K | -4.06% | — | Buy Now |
| Mar 1, 2025 | Sell | DBD | Frank Tobias Baur | EVP of Operational Excellence | 1,260 | $44.23 | $3.0B | -3.80% | +58.85% | $55.7K | -3.22% | — | Buy Now |
| Mar 1, 2025 | Sell | DBD | Jonathan Myers | EVP - Global Banking | 1,586 | $44.23 | $3.0B | -3.80% | +58.85% | $70.1K | -3.93% | — | Buy Now |
| Mar 1, 2025 | Sell | DBD | Ilhami Cantadurucu | EVP - Global Retail | 1,599 | $44.23 | $3.0B | -3.80% | +58.85% | $70.7K | -6.29% | — | Buy Now |
| Mar 1, 2025 | Sell | DBD | Thomas S Timko | EVP, CFO | 2,673 | $44.23 | $3.0B | -3.80% | +58.85% | $118.2K | -3.76% | — | Buy Now |
| Jan 19, 2025 | Sell | DBD | Elizabeth Christine Radigan | EVP - Chief People Officer | 746 | $44.49 | $3.0B | -3.80% | +58.85% | $33.2K | -4.11% | — | Buy Now |
| Jan 19, 2025 | Sell | DBD | Ilhami Cantadurucu | EVP - Global Retail | 977 | $44.49 | $3.0B | -3.80% | +58.85% | $43.5K | -5.39% | — | Buy Now |
| Jan 19, 2025 | Sell | DBD | Jonathan Myers | EVP - Global Banking | 1,101 | $44.49 | $3.0B | -3.80% | +58.85% | $49.0K | -3.89% | — | Buy Now |
| Jan 19, 2025 | Sell | DBD | Thomas S Timko | EVP, CFO | 1,343 | $44.49 | $3.0B | -3.80% | +58.85% | $59.8K | -2.76% | — | Buy Now |
| Jan 19, 2025 | Sell | DBD | Octavio Marquez | President and CEO | 3,176 | $44.49 | $3.0B | -3.80% | +58.85% | $141.3K | -2.31% | — | Buy Now |
| Nov 12, 2024 | Buy | DBD | Thomas S Timko | EVP, CFO | 360 | $40.75 | $3.0B | -3.80% | +58.85% | $14.7K | +0.75% | — | Buy Now |
| Nov 12, 2024 | Buy | DBD | Octavio Marquez | President and CEO | 1,690 | $40.84 | $3.0B | -3.80% | +58.85% | $69.0K | +0.62% | — | Buy Now |
| Nov 12, 2024 | Buy | DBD | Frank Tobias Baur | EVP of Operational Excellence | 5,310 | $41.42 | $3.0B | -3.80% | +58.85% | $220.0K | +21.89% | — | Buy Now |
| Aug 27, 2024 | Buy | DBD | Frank Tobias Baur | EVP of Operational Excellence | 1,150 | $40.58 | $3.0B | -3.80% | +58.85% | $46.7K | +4.98% | — | Buy Now |
| Aug 9, 2024 | Buy | DBD | Octavio Marquez | President and CEO | 1,100 | $37.34 | $3.0B | -3.80% | +58.85% | $41.1K | +0.82% | — | Buy Now |
| Aug 9, 2024 | Buy | DBD | Thomas S Timko | EVP, CFO | 1,400 | $38.71 | $3.0B | -3.80% | +58.85% | $54.2K | +2.99% | — | Buy Now |
| May 7, 2024 | Buy | DBD | Frank Tobias Baur | EVP of Operational Excellence | 4,200 | $39.46 | $3.0B | -3.80% | +58.85% | $165.7K | +22.21% | — | Buy Now |
| May 6, 2024 | Buy | DBD | Octavio Marquez | President and CEO | 513 | $38.90 | $3.0B | -3.80% | +58.85% | $20.0K | +0.19% | — | Buy Now |
| Mar 13, 2024 | Buy | DBD | Octavio Marquez | President and CEO | 1,500 | $34.11 | $3.0B | -3.80% | +58.85% | $51.2K | +0.38% | — | Buy Now |
| Nov 13, 2023 | Buy | DBD | Octavio Marquez | President and CEO | 1,000 | $21.50 | $3.0B | -3.80% | +58.85% | $21.5K | +90.91% | — | Buy Now |
| Aug 30, 2023 | Buy | DBD | Octavio Marquez | Board Chair, President and CEO | 1,000 | $18.69 | $3.0B | -3.80% | +58.85% | $18.7K | +1000.00% | — | Buy Now |
| Aug 14, 2023 | Buy | DBD | Octavio Marquez | President and CEO | 100 | $23.69 | $3.0B | -3.80% | +58.85% | $2.4K | +0.03% | — | Buy Now |
| Aug 14, 2023 | Buy | DBD | Octavio Marquez | President and CEO | 100 | $23.69 | $3.0B | -3.80% | +58.85% | $2.4K | — | — | Buy Now |